Pharmacological researchHumansDiabetes MellitusType 2ObesityAnimals
IUPHAR review: From foe to friend: Repurposing glucagon to treat obesity and type 2 diabetes.
Andrew J Elmendorf, Mostafa Yousefian, Il-Man Kim, J Andrew Hardaway, Kirk Habegger, Jonathan N Flak
Published: 202610.1016/j.phrs.2025.108077
Abstract
The epidemics of metabolic disease, in the form of obesity and type 2 diabetes, are a growing public health concern. However, incretin-based therapeutics have transformed our ability to address these diseases. While this current generation of increti…
Preview only. Read the full abstract at the source